Beaird Harris Wealth Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2
Closed -$530 744
2026
Q1
$530 Hold
2
﹤0.01% 563
2025
Q4
$569 Hold
2
﹤0.01% 588
2025
Q3
$646 Buy
+2
New +$546 ﹤0.01% 594
2023
Q1
Sell
-35
Closed -$7.29K 695
2022
Q4
$7.29K Buy
+35
New +$7.69K ﹤0.01% 363

Other funds holding RMD

Beaird Harris Wealth Management's RMD Position: Q2 2026 in Review

Beaird Harris Wealth Management sold out of ResMed (RMD) in Q2 2026, closing a stake of 2 shares — an estimated $530 sold.

Beaird Harris Wealth Management first reported a position in RMD in Q4 2022 and held it in 4 quarters. The position peaked at $7.29K in Q4 2022. 103 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Beaird Harris Wealth Management reported no remaining ResMed position as of Q2 2026 after selling out during the quarter.
  • Beaird Harris Wealth Management sold 2 ResMed shares in Q2 2026, an estimated $530.
  • Beaird Harris Wealth Management first reported a position in ResMed in Q4 2022 and held it in 4 quarters.
  • Beaird Harris Wealth Management's ResMed position peaked at $7.29K in Q4 2022.
  • 103 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Beaird Harris Wealth Management's 13F filing for Q2 2026, filed 8 Jul 2026.